… therapeutic approach to AD, we can identify three important fronts: the approved drugs
currently available for the treatment of the disease… and donepezil; therapies under investigation …

… targeting different pathological pathways currently under clinical evaluations. Multi-target
therapies as an emerging strategy for Alzheimer’s disease treatment will be highlighted. …

… the disease, and its dyshomeostasis has shown a crucial role in AD onset. Therefore, many
… -targeted therapies have been investigated. Here, we will systematically review recent (from …

… The current article aimed to summary and highlight advances in recent research on the …
Although there is a great effort to identify new therapeutic strategies in order to overcome the …

… Aβ-protein-targeted therapeutic strategies are thus a promising disease-modifying approach
for the treatment and prevention of AD. This review summarizes recent findings on Aβ-…

… in treatment of Alzheimer’s disease along with studies and shreds of evidence that testify
importance of these new molecules and candidates in establishing successful therapy. …

… of therapeutics for Alzheimer’s disease are cholinesterase and β-secretase enzymes. In this
review, we discuss recent … as potential therapeutics for this devastating disease. In addition, …

… therapy, and clinical failure of candidates related to newly available targets. The present
review … of the AD and potential therapeutic strategies, enlightening perceptions into structural …

… complementary therapeutic strategy in mild cognitive impairment and AD. Here, we present
… Critical Issues: Most of the disease-modifying therapeutic strategies for AD under evaluation …

… the most recent data on potential disease-modifying therapies for this pathology that have
been developed or are under development. In fact, we focused on the therapies under clinical …